Next Article in Journal
Frequency of Semen Collection Affects Ram Sperm Cryoresistance
Next Article in Special Issue
Yellow Lamb Disease (Clostridium perfringens Type A Enterotoxemia of Sheep): A Review
Previous Article in Journal
Evaluation of a Novel DNA Vaccine Double Encoding Somatostatin and Cortistatin for Promoting the Growth of Mice
Previous Article in Special Issue
Anaemia in Lambs Caused by Mycoplasma ovis: Global and Australian Perspectives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Fasciolosis—An Increasing Challenge in the Sheep Industry

Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, N-4325 Sandnes, Norway
*
Author to whom correspondence should be addressed.
Animals 2022, 12(12), 1491; https://doi.org/10.3390/ani12121491
Submission received: 27 April 2022 / Revised: 4 June 2022 / Accepted: 6 June 2022 / Published: 8 June 2022
(This article belongs to the Special Issue Anaemia Associated Disorders in Sheep)

Abstract

:

Simple Summary

Fasciolosis caused by Fasciola hepatica is a serious disease and a huge challenge in the sheep industry. The disease has several clinical manifestations including acute death, anemia, ill-thrift and loss of body condition. Climate change with milder temperatures and heavier rainfall will increase the risk of fasciolosis. Grazing management and treatment with flukicide are at present the only options to restrain F. hepatica infection. However, control possibilities are challenging, and resistance to flukicide drugs is increasing. Diagnostic improvements, targeted treatment and vaccines will hopefully increase animal health and welfare on fluke infested pastures in the future.

Abstract

The liver fluke Fasciola hepatica may cause severe infection in several mammalian species, including sheep and humans. Fasciolosis is a parasitic disease occurring worldwide in temperate climates and involves intermediate lymnaeid snails as vectors, in Europe the pond snail Galba truncatula in particular. In the sheep industry, the disease is a serious welfare and health problem. Fasciolosis is usually classified as acute, subacute or chronic according to the number and stage of flukes present in the liver, but with a considerable overlap. Acute disease, associated with a large number of migrating larvae, often results in sudden death due to acute and massive hemorrhage, while chronic fasciolosis is characterized by anemia, hypoalbuminaemia and weight loss. The management of fasciolosis is an increasing challenge in the sheep industry. Early diagnostic tests are limited. Protective immunity against liver flukes in sheep is low or lacking, and vaccines are not yet available. Treatment and control possibilities are challenging, and resistance to flukicide drugs is increasing. In addition, climate change with warmer and more humid weather will have a substantial effect on the establishment of both flukes and snails and will most likely increase the future distribution of F. hepatica.

1. Introduction

Fasciolosis is a worldwide disease in several mammalian species, caused by liver flukes in the genus Fasciola, namely F. hepatica and F. gigantica. The two species differ in size, but hybrids may occur forming intermediate forms in areas where the two species overlap [1]. It has earlier been estimated that around 550 million cattle and sheep are infected with F. hepatica worldwide [2]. Fasciolosis causes a huge financial loss especially to farmers, but also to butchers and consumers. The infection is considered a major public health problem, and it is estimated that between 50–100 million humans may be infected via contaminated water and vegetables, mostly due to ingestion of watercress (Nasturtium officinale) [1,3,4]. In the present study we will only focus on F. hepatica infection in sheep.
Liver fluke infection affects both productivity and welfare, and represents a considerable economic burden on livestock farming, with subclinical losses contributing a large proportion of the cost, including reduced milk yield, fertility and growth rates [5,6]. Fasciolosis in sheep has also been associated with a variety of conditions including black disease (infection by Clostridium novyi), parasitic gastroenteritis and metabolic diseases, especially around lambing time, such as hypocalcaemia and pregnancy toxaemia [7]. It is also a predisposing risk factor for mastitis [8], and inflammatory mediators from liver damage may affect early pregnancy [9].

2. Life Cycle

The life cycle involves different developmental stages in the following order: egg–miracidium–sporocysts–rediae–cercariae–metacercariae–juveniles–adults. One single fluke may produce around 25,000 eggs per day [10]. At temperatures between 0–10 °C, the eggs may remain viable for at least two years, but are killed if exposed to temperatures below −5 °C for more than two weeks [11]. The miracidium stage develops in the eggs at temperatures above 10 °C. Development time is around 6 weeks at 15 °C and 10 days at 22 °C. Light is essential for hatching, while the eggs must be free from feces and completely covered with a film of moisture before further development. After hatching, the miracidium moves by cilia and seeks to find a snail. Indirect hosts of Fasciola are freshwater snails of the family Lymnaeidae, of which the pond snail Galba truncatula seems to be the main host in Europe [1]. Although G. truncatula is normally dependent on water, it can survive periods of drought [11]. Permanent habitats include banks of ditches, streams and the edges of small ponds. However, following heavy rainfall or flooding, temporary habitats may include wheel ruts and rain ponds [7].
In the snail, the miracidium develops into sporocysts, later to rediae, and then to the final stage, the cercariae. More than 600 cercariae develop from each miracidium, and about five weeks after having entered the snail, the cercariae may be shed if the temperature and moisture are favourable. Cercariae swim to the herbage on which they attach, lose their tails, secrete a tough cyst wall and become metacercariae. Under optimal conditions, they can survive for a year, but many are lost due to desiccation and freezing [11].
Once ingested by the sheep, the metacercariae excyst in the duodenum and release juveniles that penetrate the intestinal mucosa and traverse the peritoneal cavity to reach the liver capsule, which they penetrate. They migrate through the liver parenchyma to end up in the bile ducts, where they mature to become adult flukes and are then leaf-shaped and approximately 2.5 cm long. The flukes are hermaphrodites, and egg-laying starts about 10–12 weeks after the initial infection. In the bile ducts, they can live for many years.
Infection mainly occurs on pasture, but infection through ingestion of silage may occur, although proper anaerobic fermentation results in loss of viability of metacercariae within two weeks, while they may remain viable for up to 10 weeks in spoiled silage [12]. In addition, experimental studies indicate that metacercariae may remain viable for 50 days within dry hay, although contaminated and poorly stored hay may contain F. hepatica for several months [13].
At least in north-western Europe, infection in ruminants can be split into two major infection peaks, “winter” infection and “summer” infection [14]. Summer infection is characterized by the infection of snails in May/June, with production of metacercariae in August/September, while in the case of winter infection, snails are infected in late autumn. In the latter case, the infection overwinters in the snails and metacercariae are already available from May to July. Summer infection seems to be the dominant infection pattern in northern Europe [15], but according to climatic models, there will be an increase in winter infection in the future [16]. However, a considerable infection overlap may occur in different areas, especially with a long grazing period. The occurrence and frequency of infection will also depend on local environmental factors, such as snail habitat availability and grazing management [15].

3. Pathogenesis

The juvenile and adult flukes have an outer surface called the tegument that protects the fluke from enzymes and immune attacks, but also suppresses the host’s immune system [17]. The flukes mechanically damage the liver tissue while moving, in addition to feeding on the tissue. The regenerative capacity of the liver is high and will be initiated by the moving parasites, and this can be seen from an influx of mononuclear cells and eosinophils and subsequent fibrosis. The rapid movement of the flukes is a way to escape the immune system. In the acute phase, F. hepatica will mount a mixed cellular (Th1) and humoral (Th2) immune response. When the infection progresses, the Th2 response will increase and the Th1 response will decrease. In addition, the flukes release immunomodulatory molecules to facilitate survival both in the acute and the chronic stage of the infection [18]. This also increases susceptibility for bacterial infections. When the flukes end up in the bile ducts, they start to feed on blood, bile, lymph and tissue, and anemia and hypoproteinaemia develop. The tegument has spines that can be used for puncturing blood vessels [17]. Sheep do not develop protective immunity against F. hepatica [11].

4. Clinical Signs

Fasciolosis is usually classified as acute, subacute or chronic related to clinical appearance, mainly correlated to the number and stage of flukes present in the liver, although with a considerable overlap.
Acute disease, associated with larval migration of a large number of juveniles over a short period of time, often results in sudden death due to acute and massive hemorrhages. However, trickle infection over weeks or months is not uncommon. Acute and chronic infection may therefore occur simultaneously [19]. Examination of other sheep in the same flock may show lethargic individuals, with pale mucosa, and exhibiting dyspnea. Rough handling can cause liver rupture and subsequent death. Differential diagnoses may include haemonchosis, clostridial infections and acute “pasteurellosis” [7].
In the subacute phase, there is a gradual loss of body condition and infected animals may show ill-thrift. Examination of affected animals will demonstrate pale mucosae. Blood samples will reveal a hypochromic macrocytic anemia, low packed cell volume, hypoalbuminemia, and elevated liver enzymes (AST, GGT, GLDH). Death may also occur. At necropsy, a large number of immature flukes is detected in the liver parenchyma, although adult flukes may also be present in the major bile ducts. In the autumn, many lambs can be slaughtered with subacute fasciolosis that exhibit rather extensive changes in the liver, but without clinical signs.
Chronic fasciolosis is the most common manifestation of the disease complex. Progressive loss of the condition is typical. Anemia can be severe, and the mucosae are often extremely pale. Death may occur especially in late pregnancy, although many sheep show no more than ill-thrift if the fluke burden is low. In addition, submandibular oedema is typical for the chronic form, and fluke eggs will be present in feces. Chronic fasciolosis is also characterized by hypoalbuminemia, eosinophilia and elevated liver enzymes. Differential diagnoses are haemonchosis, malnutrition, cobalt deficiency and other conditions related to ill-thrift, such as Johne’s disease and scrapie [20].

5. Gross Pathology

Early changes affect the liver capsule and surface, especially the left diaphragmatic surface [21]. There can be fibrin and thread-like hemorrhagic areas on the surface after the invasion of juvenile flukes. These young flukes will migrate through the parenchyma. On the cut surface, there may be focal to multi-focal pale necrotic areas and bleedings in the sub-acute stage, and juvenile flukes can be found in the liver parenchyma. If the invasion is massive, larger and fatal hemorrhages can occur. In such cases, the mucous membranes, carcass and organs will be pale. There can be large blood clots associated with ruptures in the liver, and free blood in the abdomen. Later in the subacute stage, liver changes may vary from focal thread-like pale migratory patterns, including fibrous tags on the surface, to rather extensive changes affecting both the parietal and visceral surfaces. The left hepatic lobe is usually more affected than the right. In the chronic stage, there are fibrotic scars, visible as thin and elongated shallow depressions on the surface, matching the subacute changes (Figure 1a,b). The bile ducts are dilated, and the duct walls are thickened [22]. This is especially evident for the cystic duct that empties into the neck of the gallbladder and the ducts in the hilar area (Figure 1b). Larger, dilated bile ducts may also protrude on the visceral surface (Figure 1c). On the cut surface, dilated ducts with thickened wall are easily visible (Figure 1d). Mature flukes will be found in the bile ducts and in the gallbladder. The hepatic tissue consistency will be increased because of fibrosis in the triads. A low number of flukes can be encysted in the parenchyma. The cysts are most often found at the visceral surface, where they can undergo a process of caseous necrosis and mineralization [23]. In severe and advanced chronic cases, there can be extensive fibrotic areas and a loss of hepatic tissue (Figure 1d).
At necropsy of chronic cases, a pale, anemic carcass is evident. The body condition is usually poor or the animal can be cachectic. There is often subcutaneous oedema that can be generalized or concentrated to the ventral part of the head and neck (bottle jaw). Serous fluid is commonly found in the abdomen, thorax and pericardial sack as a consequence of hypoproteinaemia. The lungs are pale, presenting with a wet cut surface and fluid and foam in the airways. Acute death after treatment may occur, most probably due to a massive destruction of flukes followed by the release of toxic compounds, although the main cause is unknown. However, this fatal outcome can reveal the same chronic changes as described above, but without findings of flukes. Sometimes, flukes can enter hepatic veins by accident and end up in unusual sites such as the lungs and uterus, causing abscessation [23].

6. Histopathology

Acute and sub-acute migration tunnels are evident as hemorrhagic areas with fibrin and degenerate hepatocytes, usually 2–3 mm in diameter (Figure 2a) [23]. Eosinophils will invade these areas early. Necrotic and degenerate tissue will be removed by macrophages and giant cells (Figure 2b) and replaced by granulation tissue rich in lymphocytes and eosinophils. In chronic cases, portal fibrosis with bile duct hyperplasia and infiltration of mononuclear cells and eosinophils will be evident (Figure 2b).

7. Diagnosis

The diagnosis in live animals is based on fecal examination, clinical presentation, hematology, serology, and molecular methods. However, all the diagnostic tests have limitations, especially for detecting early infection.
Coproscopy (flotation technique) is commonly used in diagnostics. The test is specific for detecting current infections, although challenging to use when the parasite burden is low. In addition, coproscopy does not detect non-reproducing immature stages and may also be unsuitable for large-scale and flock level testing [24].
Serological techniques increase diagnostic sensitivity, and several ELISA tests are commercially available [19,24]. Antibodies against F. hepatica can be detected 2–4 weeks after ingestion of metacercariae [25,26]. However, the test may be unable to differentiate between current and previous infections, since antibodies may persist for months after elimination of the parasite [27]. Maternal antibodies in lambs can last for up to 12 weeks ([14], Stuen personal communication). Serological tests should therefore not be used during the first two months on pasture. In addition, there seems to be a lack of correlation between antibody titer and the fluke burden [28].
Molecular methods are available for F. hepatica detection in fecal samples, such as PCR, loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). A nested-PCR based on fecal samples may detect the infection at two weeks post infection, while with the LAMP method, the detection time can be as early as one week post infection [29,30]. RPA may be used in areas with limited resources since it does not involve thermal cycler equipment or is dependent on trained personnel [31]. However, further improvements and developments of the DNA-extraction methods are required to provide more reliable tests [32,33].
Meat inspection data can be used to diagnose F. hepatica infection, especially for slaughtered lambs, and can aid in early diagnosis before clinical signs of disease ([34], Ersdal personal communication). However, this method may lack sensitivity [35].

8. Treatment and Resistance towards Flukicides

Treatment with flukicides is often the only option to control F. hepatica infection in sheep. The ultimate aim is to use the right flukicide and dose at the right time and for the right reason in order to achieve fluke control. However, determining treatment time is challenging, since this depends on several factors, such as pasture, grazing period, infected snails, housing time and local climate.
Triclabendazole (TCBZ) is considered the drug of choice against F. hepatica due to its high efficacy against both the juvenile and adult stages. However, the continued use of TCBZ is threatened by multiple reports of resistant F. hepatica. TCBZ resistance has for instance been reported in sheep in several countries in Europe [11,36]. Other flukicides only active against adults include: albendazole, clorsulon, closantel, oxyclosantel, nitroxynil and rafoxanide [11,36]. However, resistance has already been reported for some of these [30,37,38,39,40]. To delay the onset of resistance, flukicidal drugs should be used strategically. Unfortunately, the traditional repeated blanket treatment regime has led to widespread resistance, not just to TBCZ, but also to several other flukicides [41]. Sheep do not develop functional immunity to F. hepatica and reinfection is therefore likely [11], and there is no evidence for natural innate immunity.
In case of TCBZ resistance, other flukicides such as nitroxinil and closantel may still have retained their effect in some areas [42]. However, a lack of flukicide efficacy does not necessarily mean resistance, since underdosing, inadequate storage of the anthelmintic, improperly applied anthelmintic, time of treatment or inappropriate diagnostic tests may be misinterpreted as anthelmintic resistance [43].
At present, there is no standard recognized protocol for the determination of efficacy or resistance [11]. The fecal egg count reduction test is still considered as the gold standard for the detection of anthelmintic resistance in F. hepatica, although it has several limitations because of intermittent shedding and release of eggs from the gall bladder [44,45]. Other methods to detect resistance include coproantigen ELISA and the Fasciola egg hatch test (FEHT) [45,46,47]. Due to the difficulties in detecting resistance based only on field trials, it has been suggested that field drug trials be combined with an in vitro test such as FEHT in order to verify resistance [43].
Quarantine treatment should be implemented for all purchased animals to avoid pasture contamination. If signs of fasciolosis persist following treatment, fecal examination should be performed three weeks after treatment. If eggs are still present, affected animals may be treated with an alternative flukicide, if possible [7]. There is also a growing concern related to drug residues in food and the impact they may have on the local environment [48].
No vaccine is currently available. Immune suppression and modulation by F. hepatica prevent the development of protective immunity by the host and have for decades challenged the efficiency of a potential vaccine. However, recent vaccine developments through genomic, transcriptomic and proteomic approaches are promising [49,50,51], in which the goal is to identify key molecules and antigen/adjuvant combinations that stimulate an adequate level of protective immunity [41,50,52]. The whole genome sequence of F. hepatica will hopefully accelerate this development [53].

9. Pasture Management

In areas where fluke infection is endemic, flukicidal drugs should be used in combination with grazing strategies. Grazing management is important to reduce exposure to liver flukes on pasture as well as the spread of anthelmintic resistance, and seems to be the most crucial factor for reducing the risk of Fasciola infection [34]. A fluke control management plan should be implemented, including investigation of all cases of sudden death, ill-thrift and weight loss in the actual flock. Fluke egg counts should be performed regularly. Data from abattoirs concerning liver condemnation due to liver flukes should be made available in order to monitor the occurrence of fluke infections. Risk pasture and risk periods should be identified based on annual rainfall, humidity, soil type and moisture, flock size, grazing period, availability of fresh grass, and other potential hosts (such as cattle or cervids) using the same grazing areas [54]. Climates with a high temperature and heavy rainfall have an important effect on the epidemiology of F. hepatica and may increase the risk of infection. Ongoing climate change may therefore extend the fluke transmission season by up to four months in northern Europe [55].
Fencing off or draining high-risk areas may be an alternative, although it may be difficult to identify snail habitats, as they can be localized and temporary [11]. Sheep should, if possible, avoid grazing snail-infected pastures in high-risk periods.
In some countries, weather forecasting systems have for years been available to help farmers decide when to treat [14,56]. Wet weather leading to standing water during the time of year when the temperature is above 10 °C but below 30 °C seems to be the key feature for identifying high-risk periods. However, drought conditions can lead to higher infection levels, as livestock may congregate around remaining drinking and grazing areas [11]. Meteorological (temperature, evaporation, rainfall) and soil data combined with laboratory (FEC, necropsy, serology, DNA methods) and slaughterhouse data should be used in future liver fluke forecast. Investigations of the environmental DNA of snails and F. hepatica may also be a tool for risk assessment and fluke control [57].
Another option may be reducing the population of infected snails in wet areas. Drainage and closure of open ditches are long-term methods to eradicate snail habitats permanently, but these may not be practical. Since several species, including cattle and wild species such as deer, rabbits and hares, can be infected with F. hepatica and function as reservoir hosts, it may be difficult to reduce the infection pressure in sheep flocks on infected pastures. In addition, G. truncatula may arrive from surrounding areas; a migration distance of up to 30 m has been observed [27]. Snail control using molluscicides should not be used due to adverse environmental effects.
On the basis of recent studies, it seems that there is a genetic and breed predisposition in susceptibility to liver fluke infection. However, potential breed and genetic differences should be elaborated more in the future [42].

10. Conclusions

Fasciola hepatica is an important trematode of domestic ruminants in areas where the environment is suitable for the intermediate host and causes a substantial economic loss due to death, wasting disease, production losses and the cost of treatment and prophylaxis. Grazing management and treatment with flukicide are, at the moment, the only options to control F. hepatica infection. A control management plan should be implemented in relevant areas, including investigations of all cases of death, ill-thrift and chronic wasting conditions. Risk pastures should be identified, reduced and avoided based on weather forecasts or historical data. Strategical flukicide treatment should be implemented to remove both immature and adult flukes.
Challenges related to fasciolosis in sheep will most probably increase and spread in the years to come due to climate change. Milder temperatures, heavier rainfall and a longer grazing period will improve the persistence of both the parasite and its intermediate hosts. The development of an accurate, rapid and cost-effective diagnostic test will hopefully allow farmers to treat animals earlier and in a more efficient and targeted manner in the future, and delay the spread of flukicide resistance. A commercial vaccine will also hopefully be available to increase the health and welfare of sheep on fluke-infested pasture.

Author Contributions

Conceptualization, S.S.; writing—original draft preparation, S.S.; writing—review and editing, S.S. and C.E., visualization, C.E. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mas-Coma, S.; Valero, M.A.; Bargues, M.D. Fascioliasis. Adv. Exp. Med. Biol. 2019, 1154, 71–103. [Google Scholar] [PubMed]
  2. Boray, J.C. Disease of Domestic Animals Caused by Flukes; Food and Agricultural Organisation of the United Nations: Rome, Italy, 1994; p. 49. [Google Scholar]
  3. Mehmood, K.; Zhang, H.; Sabir, A.J.; Abbas, R.Z.; Ijaz, M.; Durrani, A.Z.; Saleem, M.H.; Ur Rehman, M.; Iqbal, M.K.; Wang, Y.; et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Microb. Pathog. 2017, 109, 253–262. [Google Scholar] [CrossRef] [PubMed]
  4. Fairweather, I.; Brennan, G.P.; Hanna, R.E.B.; Robinson, M.W.; Skuce, P.J. Drug resistance in liver flukes. Int. J. Parasitol. Drugs Drug. Resist. 2020, 12, 39–59. [Google Scholar] [CrossRef] [PubMed]
  5. Mazeri, S.; Rydevik, G.; Handel, I.; Bronsvoort, B.M.D.; Sargison, N. Estimation of the impact of Fasciola hepatica infection on time taken for UK beef cattle to reach slaughter weight. Sci. Rep. 2017, 7, 7319. [Google Scholar] [CrossRef]
  6. Charlier, J.; De Meulemeester, L.; Claerebout, E.; Williams, D.; Vercruysse, J. Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fasciolosis in cattle. Vet. Parasitol. 2008, 153, 44–51. [Google Scholar] [CrossRef]
  7. Mitchell, G.B.B. Liver fluke. In Diseases of Sheep, 4th ed.; Aitken, I.D., Ed.; Blackwell Publishing: Oxford, UK, 2007; pp. 195–204. [Google Scholar]
  8. Mavrogianni, V.S.; Papadopoulos, E.; Spanos, S.A.; Mitsoura, A.; Ptochos, S.; Gougoulis, D.A.; Barbagianni, M.S.; Kyriazakis, I.; Fthenakis, G.C. Trematode infections in pregnant ewes can predispose to mastitis during the subsequent lactation period. Res. Vet. Sci. 2014, 96, 171–179. [Google Scholar] [CrossRef]
  9. Sargison, N.D.; Scott, P.R. Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland. Vet. Rec. 2011, 168, 159. [Google Scholar] [CrossRef]
  10. Happich, F.A.; Boray, J.C. Quantitative diagnosis of chronic fasciolosis. 2. The estimation of daily total egg production of Fasciola hepatica and the number of adult flukes in sheep by faecal egg counts. Aust. Vet. J. 1969, 45, 329–331. [Google Scholar] [CrossRef]
  11. Howell, A.K.; Williams, D.J.L. The Epidemiology and Control of Liver Flukes in Cattle and Sheep. Vet. Clin. N. Am. Food Anim. Pract. 2020, 36, 109–123. [Google Scholar] [CrossRef]
  12. John, B.C.; Davies, D.R.; Howell, A.K.; Williams, D.J.L.; Hodgkinson, J.E. Anaerobic fermentation results in loss of viability of Fasciola hepatica metacercariae in grass silage. Vet. Parasitol. 2020, 285, 109218. [Google Scholar] [CrossRef]
  13. Enigk, K.; Hildebrandt, J. Zur Lebensdauer Der Metacercarien von Fasciola hepatica im heu. Tierärztl. Umsch. 1964, 19, 592–599. [Google Scholar]
  14. Ollerenshaw, C.B.J.; Rowlands, W.T. A method of forecasting the incidence of fascioliasis in Anglesey. Vet. Rec. 1959, 71, 591–598. [Google Scholar]
  15. Novobilský, A.; Engström, A.; Sollenberg, S.; Gustafsson, K.; Morrison, D.A.; Höglund, J. Transmission patterns of Fasciola hepatica to ruminants in Sweden. Vet. Parasitol. 2014, 203, 276–286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Fox, N.J.; White, P.C.; McClean, C.J.; Marion, G.; Evans, A.; Hutchings, M.R. Predicting impacts of climate change on Fasciola hepatica risk. PLoS ONE 2011, 6, e16126. [Google Scholar] [CrossRef] [PubMed]
  17. Lalor, R.; Cwiklinski, K.; Calvani, N.E.D.; Dorey, A.; Hamon, S.; Corrales, J.L.; Dalton, J.P.; De Marco Verissimo, C. Pathogenicity and virulence of the liver flukes Fasciola hepatica and Fasciola gigantica that cause the zoonosis fasciolosis. Virulence 2021, 12, 2839–2867. [Google Scholar] [CrossRef]
  18. Ryan, S.; Shiels, J.; Taggart, C.C.; Dalton, J.P.; Weldon, S. Fasciola hepatica-derived molecules as regulators of the host immune response. Front. Immunol. 2020, 11, 2182. [Google Scholar] [CrossRef]
  19. López Corrales, J.; Cwiklinski, K.; De Marco Verissimo, C.; Dorey, A.; Lalor, R.; Jewhurst, H.; McEvoy, A.; Diskin, M.; Duffy, C.; Cosby, S.L.; et al. Diagnosis of sheep fasciolosis caused by Fasciola hepatica using cathepsin L enzyme-linked immunosorbent assays (ELISA). Vet. Parasitol. 2021, 298, 109517. [Google Scholar] [CrossRef]
  20. Armour, J. Liver fluke. In Diseases of Sheep, 3rd ed.; Martin, W.B., Aitken, I.D., Eds.; Blackwell Publishing: Oxford, UK, 2007; pp. 168–174. [Google Scholar]
  21. Ruiz-Campillo, M.T.; Molina Hernandez, V.; Escamilla, A.; Stevenson, M.; Perez, J.; Martinez-Moreno, A.; Donnelly, S.; Dalton, J.P.; Cwiklinski, K. Immune signatures of pathogenesis in the peritoneal compartment during early infection of sheep with Fasciola hepatica. Sci. Rep. 2017, 7, 2782. [Google Scholar] [CrossRef]
  22. Pérez-Caballero, R.; Siles-Lucas, M.; González-Miguel, J.; Martínez-Moreno, F.J.; Escamilla, A.; Pérez, J.; Martínez-Moreno, A.; Buffoni, L. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica. Vet. Immunol. Immunopathol. 2018, 202, 115–121. [Google Scholar] [CrossRef]
  23. Cullen, J.M.; Stalker, M.J. Liver and biliary system. In Jubb, Kennedy and Palmer’s Pathology of Domestic Animals, 6th ed.; Maxie, M.G., Ed.; Elsevier: St. Louis, MO, USA, 2016; pp. 258–352. [Google Scholar]
  24. Munita, M.P.; Rea, R.; Martinez-Ibeas, A.M.; Byrne, N.; Kennedy, A.; Sekiya, M.; Mulcahy, G.; Sayers, R. Comparison of four commercially available ELISA kits for diagnosis of Fasciola hepatica in Irish cattle. BMC Vet. Res. 2019, 15, 414. [Google Scholar] [CrossRef] [Green Version]
  25. Chauvin, A.; Bouvet, G.; Boulard, C. Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. Int. J. Parasitol. 1995, 25, 1227–1241. [Google Scholar] [CrossRef]
  26. Salimi-Bejestani, M.R.; McGarry, J.W.; Felstead, S.; Ortiz, P.; Akca, A.; Williams, D.J. Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation against a commercially available test. Res. Vet. Sci. 2005, 78, 177–181. [Google Scholar] [CrossRef]
  27. Knubben-Schweizer, G.; Torgerson, P.R. Bovine fasciolosis: Control strategies based on the location of Galba truncatula habitats on farms. Vet. Parasitol. 2015, 208, 77–83. [Google Scholar] [CrossRef] [PubMed]
  28. Phiri, A.M.; Phiri, I.K.; Sikasunge, C.S.; Chembensofu, M.; Monrad, J. Comparative fluke burden and pathology in condemned and non-condemned cattle livers from selected abattoirs in Zambia. Onderstepoort J. Vet. Res. 2006, 73, 275–281. [Google Scholar] [PubMed]
  29. Martínez-Valladares, M.; Rojo-Vázquez, F.A. Loop-mediated isothermal amplification (LAMP) assay for the diagnosis of fasciolosis in sheep and its application under field conditions. Parasit. Vectors 2016, 9, 73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Amiri, S.; Shemshadi, B.; Shirali, S.; Kheirandish, F.; Fallahi, S. Accurate and rapid detection of Fasciola hepatica copro-DNA in sheep using loop-mediated isothermal amplification (LAMP) technique. Vet. Med. Sci. 2021, 7, 1316–1324. [Google Scholar] [CrossRef] [PubMed]
  31. Cabada, M.M.; Malaga, J.L.; Castellanos-Gonzalez, A.; Bagwell, K.A.; Naeger, P.A.; Rogers, H.K.; Maharsi, S.; Mbaka, M.; White, A.C., Jr. Recombinase polymerase amplification compared to real-time polymerase chain reaction test for the detection of Fasciola hepatica in human stool. Am. J. Trop. Med. Hyg. 2017, 96, 341–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Arifin, M.I.; Höglund, J.; Novobilský, A. Comparison of molecular and conventional methods for the diagnosis of Fasciola hepatica infection in the field. Vet. Parasitol. 2016, 232, 8–11. [Google Scholar] [CrossRef]
  33. Calvani, N.E.D.; George, S.D.; Windsor, P.A.; Bush, R.D.; Šlapeta, J. Comparison of early detection of Fasciola hepatica in experimentally infected Merino sheep by real-time PCR, coproantigen ELISA and sedimentation. Vet. Parasitol. 2018, 251, 85–89. [Google Scholar] [CrossRef]
  34. Animalia. 2021. Available online: https://www.animalia.no/no/Dyr/sau/aktuelt---sau/store-leverikter/ (accessed on 10 May 2022). (In Norwegian).
  35. Novobilský, A.; Sollenberg, S.; Höglund, J. Distribution of Fasciola hepatica in Swedish dairy cattle and associations with pasture management factors. Geospat. Health 2015, 9, 293–300. [Google Scholar] [CrossRef] [Green Version]
  36. Beesley, N.J.; Williams, D.J.; Paterson, S.; Hodgkinson, J. Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: Possible implications for drug resistance. Int. J. Parasitol. 2017, 47, 11–20. [Google Scholar] [CrossRef] [PubMed]
  37. Fairweather, I.; Boray, J.C. Fasciolicides: Efficacy, actions, resistance and its management. Vet. J. 1999, 158, 81–112. [Google Scholar] [CrossRef] [PubMed]
  38. Martínez-Valladares, M.; Cordero-Pérez, C.; Rojo-Vázquez, F.A. Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon. Exp. Parasitol. 2014, 136, 59–62. [Google Scholar] [CrossRef] [PubMed]
  39. Hanna, R.E.; McMahon, C.; Ellison, S.; Edgar, H.W.; Kajugu, P.E.; Gordon, A.; Irwin, D.; Barley, J.P.; Malone, F.E.; Brennan, G.P.; et al. Fasciola hepatica: A comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology. Vet. Parasitol. 2015, 207, 34–43. [Google Scholar] [CrossRef] [PubMed]
  40. Novobilský, A.; Höglund, J. First report of closantel treatment failure against Fasciola hepatica in cattle. Int. J. Parasitol. Drug. Drug. Resist. 2015, 5, 172–177. [Google Scholar] [CrossRef] [Green Version]
  41. Kelley, J.M.; Elliott, T.P.; Beddoe, T.; Anderson, G.; Skuce, P.; Spithill, T.W. Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol. 2016, 32, 458–469. [Google Scholar] [CrossRef] [Green Version]
  42. Beesley, N.J.; Caminade, C.; Charlier, J.; Flynn, R.J.; Hodgkinson, J.E.; Martinez-Moreno, A.; Martinez-Valladares, M.; Perez, J.; Rinaldi, L.; Williams, D.J.L. Fasciola and fasciolosis in ruminants in Europe: Identifying research needs. Transbound Emerg. Dis. 2018, 65, 199–216. [Google Scholar] [CrossRef]
  43. Munita, M.P.; Rea, R.; Martinez-Ibeas, A.M.; Byrne, N.; McGrath, G.; Munita-Corbalan, L.E.; Sekiya, M.; Mulcahy, G.; Sayers, R.G. Liver fluke in Irish sheep: Prevalence and associations with management practices and co-infection with rumen fluke. Parasites Vectors 2019, 12, 525. [Google Scholar] [CrossRef]
  44. Novobilský, A.; Amaya Solis, N.; Skarin, M.; Höglund, J. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test. Int. J. Parasitol. Drugs Drug Resist. 2016, 6, 141–147. [Google Scholar] [CrossRef] [Green Version]
  45. Fairweather, I. Reducing the future threat from (liver) fluke: Realistic prospect or quixotic fantasy? Vet. Parasitol. 2011, 180, 133–143. [Google Scholar] [CrossRef]
  46. Novobilský, A.; Averpil, H.B.; Höglund, J. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep. Vet. Parasitol. 2012, 190, 272–276. [Google Scholar] [CrossRef] [PubMed]
  47. Alvarez, L.; Moreno, G.; Moreno, L.; Ceballos, L.; Shaw, L.; Fairweather, I.; Lanusse, C. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Vet. Parasitol. 2009, 164, 211–216. [Google Scholar] [CrossRef]
  48. Canevari, J.; Ceballos, L.; Sanabria, R.; Romero, J.; Olaechea, F.; Ortiz, P.; Cabrera, M.; Gayo, V.; Fairweather, I.; Lanusse, C.; et al. Testing albendazole resistance in Fasciola hepatica: Validation of an egg hatch test with isolates from South America and the United Kingdom. J. Helminthol. 2014, 8, 286–292. [Google Scholar] [CrossRef]
  49. Molina-Hernández, V.; Mulcahy, G.; Pérez, J.; Martínez-Moreno, Á.; Donnelly, S.; O’Neill, S.M.; Dalton, J.P.; Cwiklinski, K. Fasciola hepatica vaccine: We may not be there yet but we’re on the right road. Vet. Parasitol. 2015, 208, 101–111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Toet, H.; Piedrafita, D.M.; Spithill, T.W. Liver fluke vaccines in ruminants: Strategies, progress and future opportunities. Int. J. Parasitol. 2014, 44, 915–927. [Google Scholar] [CrossRef] [PubMed]
  51. McManus, D.P. Recent progress in the development of liver fluke and blood fluke vaccines. Vaccines 2020, 8, 553. [Google Scholar] [CrossRef]
  52. Zafra, R.; Buffoni, L.; Pérez-Caballero, R.; Molina-Hernández, V.; Ruiz-Campillo, M.T.; Pérez, J.; Martínez-Moreno, Á.; Martínez Moreno, F.J. Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep. Vet. Res. 2021, 52, 13. [Google Scholar] [CrossRef] [PubMed]
  53. Cwiklinski, K.; Dalton, J.P.; Dufresne, P.J.; La Course, J.; Williams, D.J.; Hodgkinson, J.; Paterson, S. The Fasciola hepatica genome: Gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution. Genome Biol. 2015, 16, 71. [Google Scholar] [CrossRef] [Green Version]
  54. Bennema, S.C.; Ducheyne, E.; Vercruysse, J.; Claerebout, E.; Hendrickx, G.; Charlier, J. Relative importance of management, meteorological and environmental factors in the spatial distribution of Fasciola hepatica in dairy cattle in a temperate climate zone. Int. J. Parasitol. 2011, 41, 225–233. [Google Scholar] [CrossRef]
  55. Caminade, C.; van Dijk, J.; Baylis, M.; Williams, D. Modelling recent and future climatic suitability for fasciolosis in Europe. Geospat. Health 2015, 9, 301–308. [Google Scholar] [CrossRef] [Green Version]
  56. Gaasenbeek, C.P.; Over, H.J.; Noorman, N.; de Leeuw, W.A. An epidemiological study of Fasciola hepatica in The Netherlands. Vet. Q. 1992, 14, 140–144. [Google Scholar] [CrossRef] [PubMed]
  57. Jones, R.A.; Brophy, P.M.; Davis, C.N.; Davies, T.E.; Emberson, H.; Rees Stevens, P.; Williams, H.W. Detection of Galba truncatula, Fasciola hepatica and Calicophoron daubneyi environmental DNA within water sources on pasture land, a future tool for fluke control? Parasites Vectors 2018, 11, 342. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Gross pathology of chronic fasciolosis. (a). The diaphragmatic surface of the liver is irregular with elongated shallow depressions on both the left lobe (LL) and right lobe (RL). The inset image shows a mature Fasciola hepatica. (b). On the visceral side, the cystic bile duct that empties into the gall bladder and the duct in the hilar area (arrows) is markedly dilated. The same rough surface as in image (a) is evident. (c). The cut surface shows many dilated bile ducts with thickened walls (asterisks). The liver parenchyma is marbled because of fibrosis. (d). A severely fibrotic, small, and deformed liver with a dilated gall bladder.
Figure 1. Gross pathology of chronic fasciolosis. (a). The diaphragmatic surface of the liver is irregular with elongated shallow depressions on both the left lobe (LL) and right lobe (RL). The inset image shows a mature Fasciola hepatica. (b). On the visceral side, the cystic bile duct that empties into the gall bladder and the duct in the hilar area (arrows) is markedly dilated. The same rough surface as in image (a) is evident. (c). The cut surface shows many dilated bile ducts with thickened walls (asterisks). The liver parenchyma is marbled because of fibrosis. (d). A severely fibrotic, small, and deformed liver with a dilated gall bladder.
Animals 12 01491 g001
Figure 2. Histopathological changes of subacute fasciolosis. (a) Centrally placed is a migratory tunnel (MT) with destruction of the parenchyma, hemorrhage (arrow), inflammatory cells and fibrin (asterisk). (b) View of a triad. The bile duct (BD) is surrounded by connective tissue (arrow) and towards the duct epithelium there are eosinophils (arrowhead). The asterisk marks an area with giant cells and infiltration of mononuclear cells. There is also evidence of moderate bile duct hyperplasia.
Figure 2. Histopathological changes of subacute fasciolosis. (a) Centrally placed is a migratory tunnel (MT) with destruction of the parenchyma, hemorrhage (arrow), inflammatory cells and fibrin (asterisk). (b) View of a triad. The bile duct (BD) is surrounded by connective tissue (arrow) and towards the duct epithelium there are eosinophils (arrowhead). The asterisk marks an area with giant cells and infiltration of mononuclear cells. There is also evidence of moderate bile duct hyperplasia.
Animals 12 01491 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Stuen, S.; Ersdal, C. Fasciolosis—An Increasing Challenge in the Sheep Industry. Animals 2022, 12, 1491. https://doi.org/10.3390/ani12121491

AMA Style

Stuen S, Ersdal C. Fasciolosis—An Increasing Challenge in the Sheep Industry. Animals. 2022; 12(12):1491. https://doi.org/10.3390/ani12121491

Chicago/Turabian Style

Stuen, Snorre, and Cecilie Ersdal. 2022. "Fasciolosis—An Increasing Challenge in the Sheep Industry" Animals 12, no. 12: 1491. https://doi.org/10.3390/ani12121491

APA Style

Stuen, S., & Ersdal, C. (2022). Fasciolosis—An Increasing Challenge in the Sheep Industry. Animals, 12(12), 1491. https://doi.org/10.3390/ani12121491

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop